NO940245L - Quinolin eller quinazolinderivater, deres fremstilling og anvendelse - Google Patents
Quinolin eller quinazolinderivater, deres fremstilling og anvendelseInfo
- Publication number
- NO940245L NO940245L NO940245A NO940245A NO940245L NO 940245 L NO940245 L NO 940245L NO 940245 A NO940245 A NO 940245A NO 940245 A NO940245 A NO 940245A NO 940245 L NO940245 L NO 940245L
- Authority
- NO
- Norway
- Prior art keywords
- quinoline
- preparation
- quinazoline derivatives
- integer
- nitrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1262893 | 1993-01-28 | ||
| JP20612893 | 1993-08-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO940245L true NO940245L (no) | 1994-07-29 |
| NO306992B1 NO306992B1 (no) | 2000-01-24 |
Family
ID=26348258
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940245D NO940245D0 (no) | 1993-01-28 | 1994-01-24 | Quinolin eller quinazolinderivater, deres fremstilling og anvendelse |
| NO940245A NO306992B1 (no) | 1993-01-28 | 1994-01-24 | Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940245D NO940245D0 (no) | 1993-01-28 | 1994-01-24 | Quinolin eller quinazolinderivater, deres fremstilling og anvendelse |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US5436247A (no) |
| EP (1) | EP0608870B1 (no) |
| KR (1) | KR100224135B1 (no) |
| CN (1) | CN1041520C (no) |
| AT (1) | ATE205199T1 (no) |
| AU (1) | AU673213B2 (no) |
| CA (1) | CA2114300C (no) |
| DE (1) | DE69428142T2 (no) |
| FI (1) | FI940414A (no) |
| HU (1) | HU217907B (no) |
| NO (2) | NO940245D0 (no) |
| NZ (1) | NZ250761A (no) |
| RU (1) | RU2132330C1 (no) |
| SG (1) | SG50546A1 (no) |
| TW (1) | TW256832B (no) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW232013B (no) * | 1992-04-24 | 1994-10-11 | Takeda Pharm Industry Co Ltd | |
| KR100224135B1 (ko) * | 1993-01-28 | 1999-10-15 | 다께다 구니오 | 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도 |
| ATE188377T1 (de) * | 1993-06-29 | 2000-01-15 | Takeda Chemical Industries Ltd | Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose |
| US5650410A (en) * | 1994-03-08 | 1997-07-22 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition containing quinoline or quinazoline derivatives and derivatives therefor |
| US5641788A (en) * | 1994-06-07 | 1997-06-24 | Takeda Chemical Industries, Ltd. | Quinoline derivatives and pharmaceutical composition containing them |
| EP0766681A1 (en) * | 1994-06-24 | 1997-04-09 | Takeda Chemical Industries, Ltd. | Processes for production of quinoline or quinazoline derivatives and intermediates therefor |
| US5523312A (en) * | 1994-09-27 | 1996-06-04 | Sterling Winthrop Inc. | Antipicornaviral agents |
| CA2216138A1 (en) * | 1995-04-28 | 1996-10-31 | Takeda Chemical Industries, Ltd. | Therapeutic composition for arthritis |
| DE19610882A1 (de) * | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO1998054156A1 (en) * | 1997-05-28 | 1998-12-03 | Rhone-Poulenc Rorer Pharmaceuticals, Inc. | QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| EP1354603A1 (en) * | 2000-12-26 | 2003-10-22 | Takeda Chemical Industries, Ltd. | Concomitant drugs |
| JP4498923B2 (ja) * | 2002-07-15 | 2010-07-07 | サイノファーム タイワン リミテッド | イミダゾ（１，２−ａ）ピリジン−３−アセトアミド類の調製方法 |
| WO2004041787A1 (ja) * | 2002-11-06 | 2004-05-21 | Nissan Chemical Industries, Ltd. | キノリンカルバルデヒド類の製造方法 |
| MXPA05011523A (es) * | 2003-04-30 | 2006-01-23 | Inst For Pharm Discovery Inc | Heteroarilos sustituidos como inhibidores de proteinas de tirosina fosfatasas. |
| US7937406B2 (en) * | 2003-09-11 | 2011-05-03 | Oracle America, Inc. | Mechanism for automatically establishing a resource grid |
| DE102004055633A1 (de) * | 2004-11-12 | 2006-05-18 | Schering Ag | 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| US20070225632A1 (en) * | 2006-03-21 | 2007-09-27 | David Rauser | Hydratable polymeric ester matrix for drug electrotransport |
| SG176986A1 (en) | 2009-06-25 | 2012-02-28 | Amgen Inc | Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| AU2011329806A1 (en) | 2010-11-17 | 2013-05-30 | Amgen Inc. | Quinoline derivatives as PIK3 inhibitors |
| WO2014029723A1 (en) * | 2012-08-24 | 2014-02-27 | F. Hoffmann-La Roche Ag | New bicyclicpyridine derivatives |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8307865D0 (en) * | 1983-03-22 | 1983-04-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
| CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
| TW232013B (no) * | 1992-04-24 | 1994-10-11 | Takeda Pharm Industry Co Ltd | |
| KR100224135B1 (ko) * | 1993-01-28 | 1999-10-15 | 다께다 구니오 | 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도 |
| EP0766681A1 (en) * | 1994-06-24 | 1997-04-09 | Takeda Chemical Industries, Ltd. | Processes for production of quinoline or quinazoline derivatives and intermediates therefor |
-
1994
- 1994-01-24 KR KR1019940001217A patent/KR100224135B1/ko not_active IP Right Cessation
- 1994-01-24 NO NO940245D patent/NO940245D0/no unknown
- 1994-01-24 NO NO940245A patent/NO306992B1/no unknown
- 1994-01-25 TW TW083100595A patent/TW256832B/zh active
- 1994-01-26 NZ NZ250761A patent/NZ250761A/en unknown
- 1994-01-26 CA CA002114300A patent/CA2114300C/en not_active Expired - Fee Related
- 1994-01-26 US US08/186,638 patent/US5436247A/en not_active Expired - Fee Related
- 1994-01-27 AU AU54742/94A patent/AU673213B2/en not_active Ceased
- 1994-01-27 RU RU94002335A patent/RU2132330C1/ru active
- 1994-01-27 AT AT94101144T patent/ATE205199T1/de not_active IP Right Cessation
- 1994-01-27 SG SG1996004643A patent/SG50546A1/en unknown
- 1994-01-27 EP EP94101144A patent/EP0608870B1/en not_active Expired - Lifetime
- 1994-01-27 FI FI940414A patent/FI940414A/fi unknown
- 1994-01-27 DE DE69428142T patent/DE69428142T2/de not_active Expired - Fee Related
- 1994-01-28 CN CN94101137A patent/CN1041520C/zh not_active Expired - Fee Related
- 1994-01-28 HU HU9400250A patent/HU217907B/hu not_active IP Right Cessation
-
1995
- 1995-05-08 US US08/436,629 patent/US5770602A/en not_active Expired - Fee Related
-
1997
- 1997-10-21 US US08/954,854 patent/US5932592A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2114300A1 (en) | 1994-07-29 |
| FI940414A (fi) | 1994-07-29 |
| NZ250761A (en) | 1995-03-28 |
| US5770602A (en) | 1998-06-23 |
| AU673213B2 (en) | 1996-10-31 |
| DE69428142D1 (de) | 2001-10-11 |
| KR100224135B1 (ko) | 1999-10-15 |
| RU2132330C1 (ru) | 1999-06-27 |
| DE69428142T2 (de) | 2002-07-04 |
| CN1041520C (zh) | 1999-01-06 |
| NO306992B1 (no) | 2000-01-24 |
| ATE205199T1 (de) | 2001-09-15 |
| HU9400250D0 (en) | 1994-05-30 |
| US5436247A (en) | 1995-07-25 |
| AU5474294A (en) | 1994-08-04 |
| EP0608870B1 (en) | 2001-09-05 |
| CN1105363A (zh) | 1995-07-19 |
| HU217907B (hu) | 2000-05-28 |
| FI940414A0 (fi) | 1994-01-27 |
| KR940018381A (ko) | 1994-08-16 |
| CA2114300C (en) | 2000-10-17 |
| SG50546A1 (en) | 1998-07-20 |
| HUT70194A (en) | 1995-09-28 |
| NO940245D0 (no) | 1994-01-24 |
| TW256832B (no) | 1995-09-11 |
| EP0608870A1 (en) | 1994-08-03 |
| US5932592A (en) | 1999-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO940245L (no) | Quinolin eller quinazolinderivater, deres fremstilling og anvendelse | |
| FI953968A (fi) | Antraniiliset happojohdannaiset | |
| NO900306D0 (no) | Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser. | |
| EA200100755A1 (ru) | 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты | |
| DK0471236T3 (da) | Imidazopyridinderivater og deres anvendelse | |
| NO904377L (no) | Tricykliske karbapenemforbindelser. | |
| RU94002335A (ru) | Производные хинолина или хиназолина и способ их получения | |
| DE69216509D1 (de) | Kondensierte Pyrimidinderivate, ihre Herstellung und ihre Verwendung als Antitumormittel | |
| NO931482D0 (no) | Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse | |
| ATE110081T1 (de) | Cephalosporinderivate mit in der lage 3 eine thioalkylthiogruppe. | |
| DK291488D0 (da) | Alkansulfonanilidderivater | |
| NO307883B1 (no) | Antibakterielle pyridonkarboksylsyrederivater | |
| IL74589A (en) | Method for protecting cultivated plants from the harmful effects of certain herbicides by treatment with quinoline derivatives | |
| ATE169015T1 (de) | Aminobenzoesäure derivate | |
| ATE205209T1 (de) | Chinolincarbonsäurederivate und ihre salze | |
| GEP19960472B (en) | Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts | |
| ATE81502T1 (de) | Acylsulfonamid-derivate von alphacarbocyclyltoluyls|uren und ihre verwendung als leukotrienantagonisten. |
